Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05684276
What this trial is testing

DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors

Who this might be right for
NSCLCPancoast Tumor
Fundación GECP 22
Testing effectiveness (Phase 2)Ended earlyNCT00077103
What this trial is testing

Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 4
Not applicableLooking for participantsNCT03207854
What this trial is testing

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Who this might be right for
Healthy SubjectHematologic and Lymphocytic DisorderHematopoietic and Lymphoid Cell Neoplasm+2 more
University of Southern California 625
Testing effectiveness (Phase 2)Looking for participantsNCT00801489
What this trial is testing

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1+7 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03466450
What this trial is testing

Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Grupo Español de Investigación en Neurooncología 75
Testing effectiveness (Phase 2)Study completedNCT03746080
What this trial is testing

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma With Primitive Neuronal ComponentGliosarcoma+2 more
Lawrence D Recht 21
Not applicableStudy completedNCT01576289
What this trial is testing

Analysis of Biopsies From the Upper Gastrointestinal Tract

Who this might be right for
Gastroesophageal Reflux DiseaseGastritis
Medical University of Graz 600
Not applicableLooking for participantsNCT06805669
What this trial is testing

This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

Who this might be right for
Sarcoma
Mount Sinai Hospital, Canada 136
Not applicableStudy completedNCT05430841
What this trial is testing

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

Who this might be right for
Gastric CancerPancreatic CancerLiver Cancer
The First Affiliated Hospital of Xiamen University 120
Early research (Phase 1)Study completedNCT00089427
What this trial is testing

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma
INSYS Therapeutics Inc 24
Large-scale testing (Phase 3)Looking for participantsNCT07649525
What this trial is testing

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

Who this might be right for
Multiple Myeloma (MM)Plasma Cell Leukemia (PCL)
University of Leeds 1,226
Not applicableLooking for participantsNCT04942080
What this trial is testing

Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)

Who this might be right for
Myeloproliferative NeoplasmEssential ThrombocythemiaPrimary Myelofibrosis, Prefibrotic Stage+1 more
University Hospital, Angers 260
Large-scale testing (Phase 3)Study completedNCT01456325
What this trial is testing

Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Genentech, Inc. 494
Not applicableWithdrawnNCT04926168
What this trial is testing

6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)

Who this might be right for
MGMT-Methylated Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableActive Not RecruitingNCT05446779
What this trial is testing

Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

Who this might be right for
Primary AldosteronismAdrenal Cushing SyndromePheochromocytoma+1 more
Helsinki University Central Hospital 400
Testing effectiveness (Phase 2)UnknownNCT06290817
What this trial is testing

Orelabrutinib Combined With R-CDOP for DLBCL Patients With High-risk of CNS Relapse Defined by CNS-IPI

Who this might be right for
Diffuse Large B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 62
Testing effectiveness (Phase 2)Study completedNCT03158389
What this trial is testing

NCT Neuro Master Match - N²M² (NOA-20)

Who this might be right for
Glioblastoma, Adult
University Hospital Heidelberg 228
Large-scale testing (Phase 3)Active Not RecruitingNCT03914625
What this trial is testing

Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaDown Syndrome
National Cancer Institute (NCI) 6,720
Not applicableUnknownNCT01562223
What this trial is testing

Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer

Who this might be right for
Prostate Cancer
American College of Radiology Imaging Network 30
Not applicableStudy completedNCT03367260
What this trial is testing

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Duke University 115
Next Page
270